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a-fetoprotein (AFP)' is a well-characterized onco-fetal protein that is normally
expressed during embryogenesis while its reappearance in later life, other than in
normal pregnacy, usually signifies disease (1) . There are many physico-chemical
similarities between AFP and albumin and they may have comparable absorption
and transport roles for endogenous and exogenous molecules (2). The two proteins
have a significant degree of amino acid sequence homology (3), and they are im-
munologically crossreactive in the denatured state (4) . They are members of the
same multigene family that includes human group specific component (Gc), also
knownas vitamin D-binding protein (5) . In contrast to albumin, AFP isaglycosylated
protein containing 4% carbohydrate (6) . Extensive microheterogeneity ofAFPhas
been demonstrated in many species, including the human, mouse, rat, and rabbit
(reviewed in reference 7) . The exact biochemical basis of the molecular variation
that exists within the native population of AFP molecules has not been resolved,
but disparity in carbohydrate units and variable usage of glycosylation sites ofAFP
are likely to be at least partially responsible (6) . Differences in the degree of sialyla-
tion amongAFP molecules also contribute to the overallpattern of microheterogeneity
(8, 9) . Molecular variants ofAFP have been qualitatively identified on the basis of
charge differences using PAGE (8), extended agarose gel electrophoresis (10), im-
munoaffinoelectrophoresis (11), IEF (12), and anion-exchange chromatography (13) .
Variants have also been defined by differential lectin-binding properties (7). Exami-
nation ofAFP profiles during fetal ontogeny and in regenerative and carcinogenic
events has indicated that predictable changes in the ratios of isomers can occur in
normal development and in certain disease states . This raises the intriguing possi-
bility that quantitative and/or qualitativechanges in circulatinglevels ofAFP subspecies
may be ofclinical diagnostic value (14), and as well, mayhave functional significance
(10, 15). In pursuit of this latter prospect, Yachnin and coworkers (16) were able to
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gather convincing evidence that a positive correlation does indeed seem to exist be-
tween the relative concentration ofcertain molecular variants in a given fetal or tumor-
derived AFP isolate and its immunosuppressive strength. Findings by Zimmerman
et al. (15) suggested that the presence of sialic acid residues on certain AFP mole-
cules was essential for immunosuppression, while Lester et al. (16) reported other-
wise, leaving open the important question of the functional relevance of these sec-
ondary structures.
In the present investigation we have used an efficient anion exchange column linked
to an automated FPLC system, the details of which are to be published elsewhere
(van Oers, N. S. C., R. Boismenu, B. L. Cohen, and R. A. Murgita, submitted
for publication) to isolate seven molecular variants of murine fetalAFP in quantities
suitable for detailed functional studies. We show here that all the immunoregulative
activity associated with AFP is localized to a single distinct isomeric form and that
this function is not linked to sialic acid expression.
Materials and Methods
Animals.
￿
Male and female CBA/J mice were purchased from The Jackson Laboratory
(Bar Harbor, ME) and Swiss Webster mice were obtained from Charles River Breeding Labora-
tories (Montreal, Quebec). All the mice were bred and maintained in our own facilities.
Purification ofAFP .
￿
AFP was isolated from mouse amniotic fluid(MAY) ofpregnant Swiss
mice in late-stage gestation (days 16-19). Purification ofMAFderived AFP was accomplished
by antibody-agarose affinity chromatography and, when necessary, was followed by a second
step usingpreparative PAGE as described in detail elsewhere (17). Isolated AFP preparations
fulfilled strict criteria for purity, including a single Coomassie blue- or silver nitrate-stained
protein band on analytical alkaline PAGE (APAGE) and SDS-PAGE, and no detectable con-
tamination with other serum or MAF proteins according to conventional Ouchterlony gel
diffusion and immunoelectrophoresis analysis when tested at 2 mg/ml AFP
Anion Fwhange Chromatography.
￿
Chromatographic separations were performed on a prepara-
tive (MonoQHR16/10) anion-exchange column coupled to a fast protein liquid chromatog-
raphy (FPLC) system (Pharmacia Fine Chemicals, Dorval, Canada). The column was
equilibrated with 20 MM r.-histidine, pH 5.60 (buffer A), (Sigma Chemical Co., St. Louis,
MO), and fractions were eluted with a uniform linear salt gradient of 100% buffer A to 30%
buffer B (20 MM r.-histidine, 0.5 M NaCl, pH 5.60). 20-mg samples of AFP were applied
to the Mono Q HR16/10 column and bound proteins were eluted with the salt gradient at
a flow rate of 8 ml/min in a total volume of 325.0 ml. 10-ml fractions were collected, and
individual peaks, as monitored by OD2so profiles, were pooled and concentrated to 2 mg/ml
either on the basis of dry weight oflyophilized samples or by measuring the UV absorbance
at 280 nm and determining protein concentration from the OD2so reading using a predeter-
mined extinction coefficient of 0.443 for AFP.
Gel Electrophoresis.
￿
Analytical IEFPAGE was performed in 8.5% polyacrylamide gels using
a protean vertical slab gel electrophoresis unit (Bio-Rad Laboratories, Mississauga, Canada).
Briefly, 25.5 ml of acrylamide stock (30% T: 2 .67% C) (Bio-Rad Laboratories) was com-
bined with 45.0 ml of 25% sucrose and 13.5 ml of distilled water. A 5% ampholine solution
extending over a pH range of 4.2-4.9 (Pharmalyte; Pharmacia Fine Chemicals) was added
to this mixture. Polymerization was initiated with 0.6 ml of ammonium persulfate (20 mg/ml)
and crosslinking was achieved with 60 Al tetramethylethylenediamine. 2 pg of protein in a
10-Al volume was applied to the gel, and samples were subjected to electrophoresis for 5 h
at 500 V. Densitometric scans of the isoelectric variants were performed with a laser den-
sitometer (2202 Ultroscan; Pharmacia Fine Chemicals). SDS-PAGE was carried out on 12.5%
polyacrylamide gels with the Mini-Protean II apparatus (Bio Rad Laboratories). 10-Al samples
(2.0 p,g of protein) were mixed in a 1 :1 ratio with SDS sample buffer (0.0625 M Tris-HCI,
pH 6.8, 4% SDS, 20% glycerol, 0.2 M dithiothreitol, and 0.1 % bromophenol blue) and heated
at 100°C for 5 min. Electrophoresis through the resolving gel proceeded for 45-60 min atVAN OERS ET AL.
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250 V. For Western blots, 20-ng samples were prepared in SDS sample buffer and run on
12.5 % polyacrylamide gels. APAGE was performed using conditions described previously (17).
Western Blot Analysis. Electroblotting of antigen from SDS-PAGE gels onto Immobilon
polyvinylidene difluoride transfer membranes (Millipore Continental Water Systems, Bed-
ford, MA) was performed at 200-mA constant current in a transfer unit (TE-52; Hoefer
ScientificInstruments, San Francisco, CA) at 10°C overnight. After electroblotting the transfer
membrane was gently agitated for 1 h at room temperature in blocking solution (37o [wt/vol]
gelatin in 20 mM Tris, 500 mM NaGI, Tris-buffered saline [TBS] pH 7.5) and subsequently
washed twice in TBS containing 0.05% (vol/vol) Tween 20 (TTBS). Membranes were then
incubated in a 1 :500 dilution of monospecific rabbit anti-mouse AFP antisera in antibody
solution (1% [wt/vol] gelatin in TTBS). The membranes were again rinsed twice for 5 min
in TTBS and then incubated with alkaline-phosphatase-conjugated goat anti-rabbit IgG
(1 :3,000 dilution in antibody solution) for 1 h. After three successive wash steps (twice in
TTBS and once in TBS) the immunoreactive bands were detected with the BCIP/NBT color
development solution according to the manufacturer's instructions (Bio-Rad Laboratories).
Neuraminidase Digestion.
￿
10 mg of purified AFP was dialyzed overnight against 0.1 M so-
dium acetate, pH 5.0, at 4°C. The AFP was then digested with 0.2 U ofneuraminidase (Clos-
tridium perfringens; 2 U/ml) (no. 10IF8057; Sigma Chemical Co.) at 37°C for 4 h. The amount
of sialic acid remaining on AFP preparations afterneuraminidase treatment was determined
by the thiobarbituric acid (TBA) assay as described in detail below.
SialicAcidAssay.
￿
Sialic acids were liberated from AFP by mild acid hydrolysis using0.05
N H2SO4 and measured by the TBA assay (18). 200 jig of AFP or an equivalent amount
of albumin serving as a negative control in a total volume of 100 JAI was mixed with 100 11
of 0.05 N H2SO4 and incubated at 80°C for 1 h in eppendorf tubes. Aliquots of 75 pl were
removed from these digests and oxidized with 37.5 id of 25 mM periodic acid (in 0.125 N
H2SO4) at 37°C for 30 min. After this incubation, 30 Al of 2% sodium arsenite ([wt/vol]
in 0.5 N HCl) was added to the solution to neutralize excess periodate. After 2 min, the yellow
color of liberated iodine disappeared. Next, 200 p.l of 0.1 M 2TBA, pH 9.0, was added to
the reaction vessel, the mixture heated in a boiling water bath for 7.5 min, and subsequently
cooled in an ice bath. The chromophor was extracted by vigourous shaking with 750 141 of
a 5 % (vol/vol) 12 N HCl/n-butanol solution. The absorbance value of the organic phase was
measured at 549 nm with the n-butanol/acid solution serving as a blank. N-acetyl neuraminic
acid (sialic acid; Sigma Chemical Co.) was used to establish a standard curve over the concen-
tration range of 4-48 Ag/ml.
In VitroAnti-SRBCAntibody Response.
￿
Primary in vitro antibody responses were generated
by culturing 10' CBA/J spleen cells with 3 x 106 SRBC in 0.8-ml volumes in 24-well
microplates (no. 3524; Costar, Cambridge, MA) according to a modification of the original
Mishell-Dutton method as described in detail elsewhere (19).
Mitogen Transformations.
￿
Adult CBA/J Lyt-1'23 - thymocytes obtained by a conventional
two-step negative selection protocol with anti-Lyt-2 .1 (New England Nuclear, Boston, MA)
and rabbit complement (Low Tox; Cedarlane, Hornby, Ontario) were cultured to assay for
reactivity to Con A using a previously described microculture system (20). Lyt-1+23- thymo-
cytes (2.5 x 105) were cultured in 96-well round-bottomed microculture plates for 48 h with
Con A (1 wg/ml, Pharmacia Fine Chemicals). Total volume ofcell cultures was 200,ul. Cells
were maintained at 37°C in 95% humidified air and 5% C02. 6 h before harvesting, cul-
tures were pulsed with 1 jACi [3H]thymidine (66 Ci/mmole sp act) (ICN Biochemicals
Canada, St. Laurent, Quebec). Cells were harvested onto glass fiber mats with a multiple
sample harvestor (Skatron; Flow Laboratories, Inc., McLean, VA) and water-insoluble
[3H]thymidine incorporation was measured with a liquid scintillation counter (1216 Rack
Beta; LKB Instruments, Inc.). Results are expressed as mean cpm t SEM oftriplicate cultures.
BoneMarrow Cell Activation.
￿
The mitogenic effect ofwhole native AFP and its individual
isomeric forms on cultured bone marrow cells was measured by methods we have recently
described elsewhere (21). In brief, bone marrow cells were collected by flushing the tibias
and femurs of CBA/J mice with PBS using a sterile 5-ml syringe and a 25-gauge needle.
Cells were cultured in 96-well round-bottomed microtiter plates at a concentration of
2.5 x 105 cells/well in a total volume of 0.2 ml for 48 h, after which cultures were pulsed
with [3H]thymidine, harvested, and counted as described above for Con A reactions.814
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IFN-boosted In Vitro NKActivity.
￿
In vitro measurements of spontaneous and lymphokine-
boosted antiYAC NK activity inCBA/J spleen were performed as previously described (22) .
Cells were cultured in Iscove's modified DME containing 5 x 10- sM 2-ME, 100 U/ml pen-
icillin, and 100 wg/ml streptomycin, and supplemented with fresh 0.5% CBA/J normal mouse
sera (NMS) . Splenic effector cells were stimulated for 24 h with 5,000 U IFN (IFN-cx IFN-(3
from mouse fibroblasts; Enzo Biochem ., Inc ., New York, NY) in 24-well plates (Costar) at
5 x 106/ml in a total volume of 2 ml. Effector cells at an E/T ratio of 100:1 were then as-
sayed for NK lytic activity against 51 Cr-labeled YAC-1 targets .
Results
Definition ofAFP Isomeric Forms.
￿
An analysis of the protein content ofMAF on
APAGE revealed as expected the three major protein components (Fig . I A) previ-
ously defined as transferrin, AFP, and albumin (17) . The purity ofthe high-milligram
quantities ofAFP used throughout these studies was established by demonstrating
a single band on analytical APAGE (Fig . 1 B), as well as by conventional im-
munodiffusion tests with a panel ofantibodies directed against potential contaminating
material present in MAY In contrast to the single broad band ofAFP detected on
APAGE, itwas routinely possible to visualize six isoelectric variants in IEF gels (Fig
1 C), using narrow range ampholines extending over the pH range of 4.2-4.9 . The
relative amount of each AFP variant present in late gestational-stage MAF was de-
termined by densitometric scans of the IEF gels (Fig. 1 D) . As shown in Fig . 1 F,
the proportions of individual AFP subspecies in relation to the total number of na-
tive AFP molecules in the test sample was found to range from a minimum of6%
to a maximum of26% . Fig. 1 E denotes the terminology (i.e ., AFP-1 through AFP-
7) used throughout this study to identify the seven AFP isomers separable on the
MonoQcolumn linked to the FPLC system . It will be noted from data presented
FIGURE 1 .
￿
Biochemical and electrophoretic analysis of the molecular heterogeneity ofAFP (A)
Coomassie blue-stained protein pattern ofMAF, andMAF-derived purifiedAFP(B)onAPAGE
gels . The three major protein components ofMAF; albumin (Alb), AFP, and transferrin (Tf)
areshown . (C) Analytical IEF gel analysis of pure AFP showing six isoelectric variants with pIs
rangingfrom 5.1 (top) to 4.7 (bottom) . The densitometer scan oftheIEF gel (D) was used to calcu-
late the proportion of individual subspecies to the total number of native AFP molecules (F) .
The terminology used throughout this study to define the seven FPLC-generated AFPisomers
is shown (E) . (G) The sialic acid content of each isomer as determined by the TBA assay .VAN OERS ET AL .
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in Fig . 2 that the fourth isoelectric isomer defined by its pI of4.8 on IEF gels splits
into two well-defined variants on the MonoQcolumn . Finally, Fig. 1 G shows the
sialic acid content of each of the purified FPLC-defined isomers.
Quantitative Recovery ofIndividualAFPIsomers.
￿
After first establishing optimal sepa-
ration conditions for individual AFP isomers on an analytical size Mono QHR5/5
column (data not shown), we proceeded to perform separations on a preparative
MonoQHR16/10 column forthe purpose of obtaining the milligram quantities of
each isomer needed for eventual use in theplannedfunction tests . Theelution profile
shown in Fig . 2 for 20 mg of AFP was very similar to that routinely observed on
the preliminary analytical scale runs. The minor peak that consistently eluted at
-80 ml into the run failed to react with any ofour antisera directed against MAF
or NMS components and did not show a discernable Coomassie blue- or silver-
stained band on APAGE or IEF gels . Moreover, the unidentified material in this
peak was inactive in the functional tests described below. To help confirm that the
seven majorpeaks generatedon FPLC represented distinct isomeric forms of AFP,
each individual peak was examined on narrow range IEF gels. As shown in Fig.
2, insert, each of the FPLC peaks did indeed represent a unique isomer having a
different pI within thepH range of4.7-5.1, with the exception ofAFP-4 and AFP-5,
which exhibited identical protein banding at a pI of-4.8 . The seven AFP variants,
FIGURE 2 .
￿
Resolution of seven isomeric forms ofAFPon a preparative anion exchange Mono
QHR16/10 column . 20mg ofmouseAFPwas applied to theMono QHR16/10 columnequilibrated
with 20MM L-histidine, pH 5.60 . AFP isomers retained on thecolumn were eluted sequentially
with a linear salt gradient up to 0.15M NaCl over a total buffer volume of 325.0 ml . Peaks con-
taining AFP are indicated and labeled as isomeric forms AFP-1 to AFP-7 . The minor peak at
the 80-ml elution volume is notAFPand is unidentified .The insert showsaCoomassie blue-stained
IEF gel of control AFP and the AFP isomers identified in the chromatogram.816
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defined by theirhighly reproducible retention volumeson MonoQanion-exchange
column chromatography, were therefore termed AFP-1 through AFP-7, with AFP-1
appearing in the void volume . To further verify that each protein band seen in the
IEF geland defined by theFPLC chromatogram was an AFPvariant, we compared
theirmolecularmassesonSDS-PAGE and performed immunoblot analysis . As shown
in Fig. 3A, the proteins recovered from the seven peaks on the chromatogram each
had molecular masses of 69 kD, identical to that for control unfractionated AFP
Western blot analysis usingmonospecific anti-mouse AFP antibodies confirmedthat
the protein recovered from each FPLC-generated peak represented purified AFP
molecules (Fig . 3 B) . Theimmunoblots were negativewhen developedwith antisera
specific for other known components of MAF (data not shown) .
Comparative Immunoregulatory Effects of the Seven Distinct Isomeric Forms ofAFP .
￿
In
earlier studies wehad established that AFP is capableofexerting strongimmunosup-
pressive effects on in vitro anti-SRBC antibody responses (17), Lyt-1+23 - Con
A-reactive thymocyte responses (23), and NK cell activity augmented in vitro by
lymphokines (22) .
As shown in Fig . 4, A-C, a purified control AFP sample containing the full spec-
trum ofisomeric formsperformed as expected from ourpreviously published studies
by efficiently inhibiting each of the in vitro lymphocyte functions tested . However,
what is equally clear and particularly striking in this series of experiments is that
of the sevenAFP isomers tested in parallel, only AFP-1 was able to mediate a sup-
pressive effect comparable with control unfractionated AFP IsomersAFP-2 through
AFP-7 were entirely without effect in these assay cultures, even when tested at con-
centrations as high as 200 and 400 jAg/ml . Thedistinction in functional activity be-
tween AFP-1 and the other isomers is even more apparent from dilution analysis
data shown in Fig . 5. Here a representative dose-response curve extending from
100 to 0.01 jug/ml of each purified isomer shows that AFP-1 is a more efficient sup-
pressor of Lyt-1 +23- Con A thymocyte responses than is unfractionated control
AFP, while the remaining six isomers again failed at all concentrations to influence
FIGURE 3 .
￿
Molecular mass characterization
and immunoblot analysis ofAFP molecular
variants purified by FPLC anion-exchange
chromatography . 2pgofcontrolAFP or Mono
Q-definedAFPisomers AFP-1 toAFP-7 were
separated on 12.5% SDS-PAGE and stained
with Coomassie blue (A) . ForWestern blots
(B), 20 ng ofprotein containing controlAFP
or AFP-1 to AFP-7 was separated on 12.5%
SDS-PAGE andimmunoblotted with amono-
specific anti-AFP antibody. Arrows indicate
location ofmolecular masses, which include
phosphorylaseb(94 kD),BSA (67 kD), OVA
(43 kD), carbonic anhydrase (30 kD), and soy-
bean trypsin inhibitor (20.1 kD) .VAN OERS ET AL .
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FIGURE 4 .
￿
Comparative immunoregulatory
effects of the seven FPLC-defined AFP
isomers on in vitro lymphocyte functional
assays . ControlAFP and each individual AFP
isomer were tested for functional activity on
Tdependent antibody responses (A) . CBA/J
spleen cells (107) were cultured with 3 x 106
SRBC and200 Rg/ml ofNMSs control AFP,
or the indicated isomers in a total volume of
0.8 mlRPMI, 10% FCS . After 4dofincuba-
tion,anti-SRBC activity wasassayed.Bshows
adult CBA/J Lyt-1+23- thymocytes (2 .5 x
105) cocultured with 1 p,g/ml ConA and 200
jig/ml ofthe indicated proteins. Proliferative
responses were measured at 48 h of culture .
In C, mouse albumin, controlAFP, andAFP-1
to AFP-7 were tested for their suppressive ac-
tivity on IFN-boostedNK cell activity . Adult
CBA/J spleen cells were incubatedwith IFN
and the indicated proteins for 24h . After 24 h,
theNK activity ofthe cells measured against
51Cr--YAC . Bone marrow cell proliferative re-
sponses (D) were measured after culturing
normal adult CBA/J cells (2 .5 x 105)with the
indicated proteins for 48 h, as described in
Materials and Methods.
this reaction . Thus, ConA responses in the presence of various amountsofisomers
AFP-2 through AFP-7 always fell within the SEM for albumin control responses
as denoted in Fig . 5 by the dotted lines.
Recent studies by Hoskin et al . (21) have shown that cultured bone marrow cells
undergo a strong proliferative response in the presence ofAFP . We therefore exam-
ined the effect ofeach of theFPLC-separated isomerson cultured bonemarrow cells
to determine which ofthe molecular variants coulddemonstrate growth-promoting
activity. As shown in Fig . 4 D, augmented bone marrow cell proliferation in the
presence ofAFP-1 is comparable with that mediated by controlAFP, whiletheother
isomers displayed moderate stimulatory capacity that was still well above control
values in the presence of media alone or albumin .818
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FIGURE 5 .
￿
Dose-response effect of control
AFP vs . AFP-1 and the nonsuppressive iso-
mers on Con A-stimulated Lyt-1'23 - thymo-
cytes . Adult CBA/J Lyt-1'23- thymocytes
were cultured with ConA in the presence of
controlAFPand purified isomers at the con-
centrations indicated .Theboxed in area shows
control Lyt-1'23 - responses in the presence
of either mouse albumin of the Mono
Q-defined isomers AFP-2 to AFP-7 . After 48
hofculture, proliferative responses were mea-
sured by [3Hlthymidine incorporation as de-
scribed in Materials and Methods . The in-
sert showstheIEF pattern ofcontrolAFPand
AFP-1 .
The Role ofSialic Acid in AFRmediated Immunosuppressive Activity.
￿
Evidence thatsome
of the microheterogeneity ofmouseAFP could be attributable to variability in the
sialic acid (NANA) composition of its subspecies (9) prompted us to investigate the
relative amount ofNANA present in each purified AFP isomer. Usingamodification
oftheTBA assay (18), the mol ofNANA per mol of protein were calculated foreach
FPLC-defined AFP isomer. As noted in Fig . 1 G, there was a progressive increase
in sialic acid residues on AFP-2 to AFP-7, with AFP-7 having 4 mol ofNANA per
molof protein . AFP-2wasassumed to lack NANA entirely because it gave lowvalues
similar to that ofmouse albumin, a protein known to have no covalently coupled
NANA residues . It is notable that AFP-1 has a sialic acid content similar to AFP-3
even though thetwoisomers exhibit distinct pIs andFPLC retention volumes . This
finding indicates that both the anion-exchange column and IEF gels are resolving
charge differences in these isomers that are independent of sialic acid content .
Conflicting results have emerged regarding the contribution of covalently linked
sialic residues to the suppressive activity ofAFP (15, 16). Experiments were there-
fore performed in which the immunosuppressive activity ofAFP was assessed after
cleavage ofthe sialic acids by neuraminidase digestion. The effectiveness of removal
of these residues was confirmed by theTBA assay, and the data shown in Table I
indicate that there was an 80% reduction in sialic acid residues after enzyme treat-
ment of two separate AFP preparations . Thus, according to our measurements en-
zymatically treated AFP preparations usually retained between 15 and20% oftheir
sialic acid content, which might suggest the existence of an enzyme-resistant popu-
lation . More exhaustive attempts to achieve complete digestion, including increased
enzyme to protein ratios, longer incubation times, recycling on Sepharose-bound
neuraminidase columns, and the use of neuraminidase derived from Vibrio cholera,
failed to increase the efficiency of digestion . The functional activity of two different
enzyme-treated AFP preparations was determined by measuring their effect at 200
jig/ml on Con A-stimulated Lyt-1'23- thymocyte responses . As shown in Table 1,
the desialylated AFP preparations were only slightly less suppressive than the un-VAN OERS ET AL.
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TABLE I
Effects of Neuraminidase Digestion on AFP-mediated Suppressive Activity
" Sialic acids were liberated from the protein by mild acid hydrolysis, and the free sialic acid
content was measured by a modification of the TBA assay.
t Adult CBA/J Lyt-1 * 23- thymocytes (2 .5 x 105) were cocultured with 1 lAg/ml of Con A
and 200 Wg/ml of the indicated proteins. Proliferative responses were measured at 48 h of
culture.
5 The moles of NANA per mole of AFP was determined from three different preparations of
AFP.
The experiment described above was repeated under the identical conditions.
II 10 mg of control AFP was digested with 0.2 U neuraminidase (C. Perfringens) for 4 h at 37°C
in 0.1 M Na acetate, pH 5.0.
treated control AFP While a possible contribution to the suppressor mechanism
by the small amount of enzyme-resistant sialic acid residues remaining on the
desialylated samples cannot be excluded, the most likely conclusion from these ex-
periments is that sialic acids play no central role in mediating the immunosuppres-
sive effect ofAFP This conclusion is supported by our findings that the immunosup-
pressive AFP-1 isomer expresses essentially the same amount of sialic acid as does
the nonsuppressive AFP-3 isomer.
Discussion
Accumulating evidence continues to support the concept put forth by Murgita
andTomasi in 1975 (17, 24)that immunoregulation is oneofthebiological functions
ofAFP The most well-studied modulating influence ofAFP on lymphocyte responses
is immunosuppression (reviewed in reference 25). However, AFP may also exert a
mitogenic or growth-promoting influence on in vitro cell growth (21), which is to
some extent reminiscent of previously observed effects by albumin and transferrin
(26), two serum proteins shown to be related to AFP in terms ofimmunologic cross-
reactivity of their unfolded polypeptide chains (4). Recent evidence points to the
fact that the immunosuppressive effects of AFP are most pronounced on autoim-
mune reactions as measured both in vitro (20, 27-29) and in vivo (30, 31). This
has led us to propose that in order to ensure normal embryonic development, AFP
molecules may have evolved a specialized regulatory function to selectively control
potentially harmful expressions of autosensitization (32). According to this reasoning,
the developing immune system of the fetus andthe newborn, as well as certainadult
maternal immunoresponsive elements (33), are subduedby circulating immunoregula-
tory AFP molecules in such a manner that they function sufficiently well to protect
against such external insults as infectious agents and alloaggressive maternal lym-
phocytes, while at the same time allowing for appropriate checks on unwarranted
autoaggressive self-recognition events.
AFP is known to exist as a group ofclosely related molecularvariants, and studies
Sample NANA/protein'
Lyt-1
Exp.
* 23-
1
Con A thymocyte
Exp, 2
responsel
Exp. 3
mot cpm t SE
Media 77,384 t 5,148 31,531 t 3,637 94,962 t 6,522
Control AFP 3.16 t 0.505 2,919 t 293 1,749 t 450 7,887 t 523
AFP desialylatedl 0.69 t 0.12 5,969 f 734 4,719 t 1,253 ND
AFP desialylatedl 0.75 t 0.14 6,373 t 783 4,005 t 479 9,877 t 526820
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by Zimmerman et al. (8, 9) have demonstrated patterns of what appear to be pre-
cisely regulateddevelopmental shifts in the numbers and ratios of individual isomers
throughout the perinatal period . This raises the important question as to whether
the immunosuppressive activity that up to now we and many other investigators
in this area have generally ascribed to the broad population of AFP molecules pro-
duced by the fetus can be attributed instead to what is perhaps a unique molecular
variant that is under tight ontogenetic control during normal physiological condi-
tions. It is notable in this regard that there have been previous reports concerned
with attempts to correlate immunoregulatory activity with the presence of one or
more naturally occurring isomers in a given preparation of AFP (10, 15, 16).
Lester et al. (10, 16) were the first to provide evidence suggesting a connection
between theproportionsof certain electronegativeisomeric formspresent in human
fetal- and tumor-derived AFP isolates and the ability of those isolates to suppress
mitogen- and alloantigen-induced lymphocyte transformation. Thus, fetal liverAFP
was noticed to have a relatively high content of electronegative isomers, and was
found to be strongly immunosuppressive in contrast to the generally less function-
ally active tumor-derived productthat was shownto contain lowerlevels ofthe nega-
tively charged molecular variants of AFP.
Lester et al. (10, 16) also tested the immunosuppressive potency offetal liver AFP
isolates after enzymatic desialylation and showed that functional activity of these
isolates was not altered by removal of sialic acid residues. Ontogeny studies in the
murine system by Zimmerman et al. (8, 9) showed reproducible changes in the con-
centrations of individual electrophoretic variants of AFP and this was attributed
to increasing levels of sialyltransferase activity in both the yolk sac and fetal liver.
Thus, late gestational-stage AFP isolates contained a higher proportion of more
sialylated variants than did AFP preparations isolated earlier in ontogeny. When
assessing the functional activity of sialylated vs. nonsialylated forms of AFP on pri-
mary T cell-dependent antibody responses, these authors provided evidence sug-
gesting that only the more sialylated variants ofAFP were immunosuppressive (15).
This was in contrast with the findings of Lester et al. (10, 16), and thus, the role
of sialic acids in AFP-mediated immunosuppression has remained contentious.
Clarification and extension of these earlier findings have been hampered in the past
largely due to the lack of a suitable procedure to isolate individual molecular vari-
ants of AFP in quantities sufficient for detail functional studies.
Whilemany techniques have been describedfor analyzing the microheterogeneity
of AFP molecules, most have been developed and deployed primarily for analytical
purposes and, as such, are either not readily adaptable to upscaling or fail to have
the necessary resolving power required to separate on a preparative scale each of
the closely related molecular variants. To overcome such limitations we have devel-
oped a purification protocol for separating AFP into seven distinct isomeric forms
using Mono Q anion exchange columns coupled to an automated FPLC system.
The separation profile shown in Fig. 2 demonstrates the efficacy of this method for
detecting individual molecular variants of AFP and for recovering each isomer in
pure form. The use of L-histidine buffer at pH 5.60 resulted in elution of theAFP-1
isomer in the void volume while the remaining six FPLC-defined isomers were re-
tained on the column and emerged sequentially with a linear increase in salt. The
six isomers eluted with the salt gradient show alinear increase in sialic acid contentVAN OERS ET AL.
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(Fig. 1 G) extending from the AFP-2 isomer, which lacks sialic acid, to a maximum
of four residues/mol of protein for AFP-7, raising the obvious possibility that the
observed microheterogeneity is largelydue to differences in sialic acid content. How-
ever, studies by Yachnin and coworkers (16) and by us (unpublished results) clearly
show that desialylation reduces but does not abolish AFP microheterogeneity.
Moreover, isomers AFP-1 and AFP-3 as well as AFP-4 and AFP-5 express similar
contents of sialic acids (Fig. 1 G) and yet are easily distinguishable on the Mono
Qcolumn separation profiles. We have also determined in preliminary experiments
not shownhere, as has Yachnin's group previously (34), that delipidation of a native
AFP isolate has no significant effect on its isoelectric or FPLC-generated pattern
of microheterogeneity. Much of the biochemical bases for the various distinct sub-
populations of AFP molecules may therefore involve genetically determined amino
acid substitutions, rather than or in addition to ligand binding and post-synthetic
changes in chemical compositions.
While the earilier work of Lester et al. (10, 16) and Zimmerman et al. (8, 9) cited
above certainly points to the conclusion that immunosuppression is a property of
some but not all molecular variants of AFP synthesized by the normal fetus, the
results of the present investigation are the first to show conclusively and in a direct
manner that AFP-mediated immunoregulatory activity is in fact aunique property
associated with a single distinct isomeric form that represents only 6% of the fetal
population of AFP molecules. This firm conclusion was reached by purifying each
of the seven molecular variants of fetal AFP to homogeneity followed by character-
ization according to their distinct retention volumes on FPLC elution profiles, their
sialic acid content, and their molecularweight and display of specific AFP antigenic
determinants by Western blotting. Each isomer was then thoroughly tested forfunc-
tional activity using several different in vitrolymphocyte assaysystems known from
ourprevious studies (17, 21-24) to be highly sensitiveto AFP-mediated immunoregula-
tory effects. Thus, we show in Fig. 4 that the AFP-1 isomer suppresses in vitro anti-
body synthesis, T cell mitogenreactivity, and lymphokine-boosted NK activity with
equalor greater efficiency (see Fig. 5) than does a wholeunfractionated control AFP
preparation. The fact that suppression neverreaches 100% in these functional assays
agrees with earlier conclusions that a subpopulation of lymphocytes is resistant to
the inhibitory effect ofAFP (16, 35). The remaining sixisomeric forms, AFP-2 through
AFP-7, were entirely without effect in these functional assays, leaving open the in-
teresting question as to what other roles these variants may play in normal and dis-
ease states. It is possible to surmise that AFP isomers 2 through 7, which represent
>90% of thetotal number offetal AFP molecules in thecirculation, mayhave some
functions in common with albumin, such as maintaining osmotic pressure and,
through ligand-binding properties, serving as plasma carrier molecules important
for both transport and for detoxification, as in the case of estrogens where the es-
trophilic properties ofAFP is hypothesized to serve a protective role on fetal tissues
from the effects of circulating maternal estrogens (36). Experiments are presently
underway to examine these possibilities.
Also shown in Fig. 4 are data on the comparative in vitro growth-promoting effect
of control unfractionated AFP vs. each of the seven purified isomers on cultured
bone marrow cells. We have reported previously on studies showing an immunoen-
hancing effect of AFP (35) with one important functional manifestation of this ac-822
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tivity being the induction of T (37-40) and B cell-like (41-43) natural suppressor
cells. The growth-stimulating properties of AFP, as measured by increased
[3H]thymidine incorporation in cultured bone marrow cells, resides most strongly
with the AFP-1 isomer, although the other isomers show some ability to maintain
bone marrow cell growth as does albumin (Fig. 4 D). We have previously suggested
(21, 41) that the growth-promoting effect of AFP, which is particularly evident on
the bone marrow, may be an exaggerated form of a shared property with albumin,
which is known to be important for mammalian cell growth in vitro (44).
The essential biochemical distinction(s) between the immunoregulatory AFP-1
molecules and the other six isomers that lack this functional property remains to
be determined. We have stated previously (17, 45), as has Lester et al. (16), that
with available data it seems more likely that immunosuppression will prove to be
an intrinsic property of certain AFP molecules rather than being attributable, as
some have suggested (46, 47), to a putative noncovalentlybound moiety that somehow
imparts functional activity to the complex. The rationale for this reasoning is based
on our collective experience in the use of stringent purification procedures forAFP,
which have included exposure to strong denaturing agents, pH extremes, and high
salt followed by extensive dialysis. While all these conditions would tend to favor
dissociation and removalof low molecularweight moieties bound to AFPmolecules,
they fail, in our hands, to diminish functional activity of purified AFP Moreover,
Yachnin et al . (34) have successfully performed further careful studies designed to
exclude any ligand binding role for such known factors as hydrocortisone, prosta-
glandins, fatty acids, or oxygenated sterol compounds as elements contributing to
the immunosuppressive action of AFP. Nevertheless, it is still not possible to for-
mally discharge the possibility that AFP may act in conjunction with other, as yet
unidentified factors in a complicated manner in orderto impart effectivelymphocyte-
inhibiting activity. However, on the basisofthe findings in the present investigation,
any alleged cofactor involved in the immunosuppressive mechanism of AFP would
presumably have to show specificity forthe functionally active AFP-1 molecularvariant.
Experiments presently underway in our laboratory, including functional analysis
of modified synthetic and recombinant AFP peptides (48), are aimed at reaching
a definitive answer to this central question .
Summary
In this report, we examine the functional significance of the molecular micro-
heterogeneityof a-fetoprotein(AFP). In doing so, we have taken thedirect approach
of purifying the naturally occurring isomeric forms of fetal-derived AFP using a
preparative anion exchange column linked to an automated fast proteinliquid chro-
matography (FPLC) system followed by parallel testing of each isolated molecular
variant forin vitro immunoregulatory activity. The data obtained demonstrate the
presence of seven distinct variants of AFP as defined by their retention volumes on
FPLC elution profiles, by theirpIs on analytical IEF gels, and by Western blot anal-
ysis. Molecularmass determination by SDS-PAGE showed each isomer to be equiva-
lent in size to 69,000-dalton native unfractionated AFPmolecules. All the immunosup-
pressive activity of AFP was localized to a single variant representing only 6% of
the total composition of native AFP. The immunoregulating isomer termed AFP-1
was the least acidic of the seven isolated variants with a pI of 5.1 and displayed aVAN OERS ET AL.
sialic acid content of 1 mol/mol of protein. The inhibitory activity of AFP-1 could
be readily measured on T cell-dependent antibody synthesis, Con A-induced stim-
ulation of Lyt-1 +23 - thymocyte DNA synthesis, and lymphokine-activated NK cell
activity. All other isomers were without effect in these test systems. The immunosup-
pressive AFP-1 isomer also displayed the strongest growth-promoting influence on
cultured bone marrow lymphocytes. There was no correlation between functional
activity and degree of expression of sialic acid residues on the AFP molecules. These
findings demonstrate that the immunoregulating function of AFP is confined to a
distinct and relatively small subpopulation ofnative AFP molecules and should there-
fore contribute to the resolution ofoutstanding questions regarding the structure/func-
tion relationship of this onco-fetal glycoprotein.
We thank Anne Nudo, Heather Bauersfeld, and Marie Lizotte for theirexcellent assistance
in the preparation of this manuscript.
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